We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Pericardial Drain Removal Safe Following Cardiac Tamponade

By Daniel Beris
Posted on 14 Dec 2016
Print article
After treating cardiac tamponade arising from atrial fibrillation (AF) catheter ablation, pericardial drains do not need to be kept in place for an additional day, according to a new study.

Researchers at John Radcliffe Hospital (Oxford, United Kingdom) conducted a retrospective descriptive analysis study of 43 cases of cardiac tamponade resulting from complication of atrial fibrillation catheter ablation (AFCA) procedures between 2006 and 2015 in order to examine the safety of early removal of pericardial drains. The researcher compared 25 patients in whom the drain was removed early to 18 patients who underwent traditional delayed removal. Cardiac tamponade was diagnosed when pericardial effusion led to hypoperfusion and systolic blood pressure dropped below 80 mm Hg.

In cases that employed early removal strategy, the pericardial space was monitored for reaccumulation for a minimum of 30 minutes, with repeated transthoracic echocardiography. Once it reached dryness, the patient was deemed ready to leave the laboratory and the drain was left to operator discretion for removal. The delayed removal group was monitored for an extra 17 hours once no reaccumulation was confirmed. The main outcomes included need for repeat pericardiocentesis, major adverse outcomes, length of stay, and need for opiate analgesia.

The results showed that not one of the AF patients who had the drains taken out early needed repeat pericardiocentesis before hospital discharge. They also had a moderately shorter length of stay than their peers who had drain removal delayed in case of re-bleeding, and also went back on anticoagulation earlier. In addition, few patients with early removal needed opiate analgesia (8%) compared to the delayed removal group (72%). The study was published on November 15, 2016, in JACC: Clinical Electrophysiology.

“Early removal of pericardial drains after tamponade complicating atrial fibrillation catheter ablation procedures appears to be safe and effective, with re-insertion not required in this cohort,” concluded lead author Michala Pedersen, MD, and colleagues. “The traditional practice of leaving drains in situ for 12 to 24 hours may result in more patient discomfort and longer hospitalization. Additionally, there may be benefits to health economics.”

Cardiac tamponade occurs when fluid in the pericardium accumulates, resulting in compression of the heart. Symptoms typically include shortness of breath, weakness, lightheadedness, and cough. If fluid increases slowly the pericardial sac can expand to contain more than two liters; however, if the increase is rapid, as little as 200 mL can result in tamponade. When tamponade results in symptoms, drainage is necessary, by pericardiocentesis, a pericardial window, or a pericardiectomy. Tamponade due to AFCA is traditionally managed by pericardiocentesis with delayed removal of the drain (typically 12 to 24 hours later) in case of re-bleeding.

Related Links:
John Radcliffe Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Endocavity Needle Guide
Vitro PRO
New
Digital Brain Electric Activity Mapping Device
KT88

Print article

Channels

Critical Care

view channel
Image: The heart patch is produced from induced pluripotent stem cells derived heart muscle cells in a collagen hydrogel (Photo courtesy of UMG/Eva Meyer-Besting)

Heart Patch Offers Innovative Treatment Option for Advanced Heart Failure Patients

After successful preclinical testing in an animal model, the world’s first treatment involving heart tissue cultivated from stem cells has been administered to patients. This milestone is a significant... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.